Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.3750
-0.0100 (-2.60%)
Oct 15, 2025, 3:51 PM EDT
Cell Source Market Cap
Cell Source has a market cap or net worth of $17.09 million as of October 15, 2025. Its market cap has increased by 6.83% in one year.
Market Cap
17.09M
Enterprise Value
27.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.38
Market Cap Chart
Since July 1, 2014, Cell Source's market cap has decreased from 36.03M to 17.09M, a decrease of -52.58%. That is a compound annual growth rate of -6.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 18.80M | 23.17% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | 63.92M | 119.45% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 334.34M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |